OQS
CTSO icon

Occudo Quantitative Strategies’s Cytosorbents Corp CTSO Stock Holding History

Occudo Quantitative Strategies’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,367
Closed -$53K – 1222
2022
Q2 		$53K Buy
24,367
+6,092
+33% +$14K ﹤0.01% 1065
2022
Q1 		$58K Sell
18,275
-839
-4% -$3K ﹤0.01% 1067
2021
Q4 		$80K Sell
19,114
-3,198
-14% -$17.9K 0.01% 977
2021
Q3 		$181K Buy
22,312
+2,281
+11% +$18.5K 0.02% 872
2021
Q2 		$151K Buy
20,031
+3,231
+19% +$27.2K 0.02% 757
2021
Q1 		$146K Buy
+16,800
New +$160K 0.03% 666

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Occudo Quantitative Strategies's CTSO Position: Q3 2022 in Review

Occudo Quantitative Strategies sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 24,367 shares — an estimated $53K sold.

Occudo Quantitative Strategies first reported a position in CTSO in Q1 2021 and held it in 6 quarters. The position peaked at $181K in Q3 2021. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Occudo Quantitative Strategies reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 24,367 Cytosorbents Corp shares in Q3 2022, an estimated $53K.
  • Occudo Quantitative Strategies first reported a position in Cytosorbents Corp in Q1 2021 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Cytosorbents Corp position peaked at $181K in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.